نتایج جستجو برای: alzheimers diseases

تعداد نتایج: 850297  

Journal: :Tidsskrift for Den norske legeforening 2011

Journal: :Current Alzheimer Research 2007

Journal: :Tidsskrift for Den norske legeforening 2013

2016

assembly in particular is associated with a wide range of functions including cell division, cell motility and diseases such as Alzheimers' and Parkinsons'. The forces generated during the growth of native self-assemblies such as actin and microtubules is vital for cellular function. The generation of forces is achieved by a reversible polymerization of the constituent monomers (tubulin and act...

2013
Sara K. Bengtsson

..................................................................................................... v Populärvetenskaplig sammanfattning ....................................................... vii Alzheimers sjukdom ................................................................................. vii Stress och allopregnanolon .....................................................................

2016
Linnea Sandin Beau Taplin Katarina Kågedal Ann-Christin Brorsson

Alzheimer’s disease (AD) is a neurodegenerative disease and the most common cause of dementia worldwide. Apart from dominantly inherited mutations, age is the major risk factor and as life expectancy increases the prevalence for AD escalates dramatically. AD causes substantial problems for the affected persons and their families, and the society suffers economically. To date the available treat...

Journal: :Ecological genetics 2022

Amyloid protein aggregation is a key factor in the development of variety serious diseases humans, commonly named as amyloidoses (Alzheimers and Parkinsons diseases, type II diabetes, etc.), determinant protein-based inheritance lower eukaryotes. In yeast, translation termination Sup35 one most extensively studied amyloidogenic proteins. Aggregation (induction [PSI+] prion) decreases its functi...

Journal: :Tidsskrift for Den norske legeforening 2011

2015
Diane Stephenson Martha Brumfield Klaus Romero Janet Woodcock Issam Zineh Eric M Reiman Caroline Tanner Richard Mohs Walter Koroshetz Mark Forrest

Alzheimer’s disease (AD) and Parkinson’s disease (PD) pose significant challenges for successful development of new therapies, with anextremely high drug trial failure rate and yet no approved disease modifying drugs available. Given the magnitude of the challenges, it has become clear that larger collaborations and multi-partner joint efforts, pooling resources and expertise,are required for t...

Journal: :Tidsskrift for Den norske legeforening 2013

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید